Rudi Bao

Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.

Muthu Selvakumaran, Debra Pisarcik, Rudi Bao et al. · PubMed · 2003 · 316 citations

Genome Instability, Medicine, A2780 Cell Lines +12

Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.

Denise C. Connolly, Rudi Bao, Alexander Yu. Nikitin et al. · PubMed · 2003 · 315 citations

Epithelial Ovarian Cancer, Female Mice Chimeric, Immunology +22

Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-<i>N</i>-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer

Xiong Cai, Hai-Xiao Zhai, Jing Wang et al. · Journal of Medicinal Chemistry · 2010 · 258 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Pharmaceutical Chemistry +18

Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling

Changgeng Qian, Cheng-Jung Lai, Rudi Bao et al. · Clinical Cancer Research · 2012 · 236 citations

CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity

Cheng-Jung Lai, Rudi Bao, Xu Tao et al. · Cancer Research · 2010 · 211 citations · Full text

Dermatology, Cancer Biology, Tumor Biology +16